Riskpilot← Back to searchSign inGet full accessKLARDENT AB
ABActiveOrg 5569453060Turbingatan 1 BWholesale of pharmaceutical and medical goods · NACE 4646Est. 20131-4 employees
Revenue 2024
SEK 13,4M
+14% vs 2023
EBITDA margin
10.1%
-6% vs 2023
Equity ratio
61.7%
Financial strength
Net profit 2024
SEK 766K
-12% vs 2023
| Revenue | SEK 13,4M | +14% |
| EBITDA | SEK 1,3M | -6% |
| Net profit | SEK 766K | -12% |
| Total assets | SEK 8M | +12% |
| Equity | SEK 4,9M | +18% |
| Employees | — | — |
Legal name
KLARDENT AB
Org number
5569453060
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14 oktober 2013
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Import, export och återförsäljare av dentala och medicinska produkter.
Address
Turbingatan 1 B
Email
info@klardent.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 3 517 | 4 493 | 6 402 | 8 204 | 9 876 | 11 770 | 13 361 |
| Staff expenses | — | — | — | — | — | — | — | — | −1 412 | — |
| EBITDA | 484 | 473 | 449 | −277 | 515 | 1 168 | 401 | 1 299 | 1 432 | 1 345 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −1 | −9 | −23 | −33 | −58 | −70 |
| EBIT | 484 | 473 | 449 | −277 | 514 | 1 159 | 378 | 1 266 | 1 374 | 1 275 |
| Net financials | 3 | −10 | −14 | −14 | −13 | −13 | −12 | −8 | 18 | 31 |
| Profit before tax | 365 | 463 | 461 | −170 | 500 | 1 146 | 366 | 939 | 1 092 | 972 |
| Tax | −80 | −102 | −102 | −0 | −72 | −247 | −76 | −193 | −224 | −206 |
| Net profit | 285 | 361 | 359 | −170 | 428 | 899 | 290 | 746 | 869 | 766 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 662 | 2 499 | 2 693 | 2 776 | 3 314 | 4 766 | 4 897 | 5 926 | 7 120 | 8 010 |
| Equity | 395 | 756 | 1 115 | 946 | 1 374 | 2 273 | 2 564 | 3 309 | 4 178 | 4 944 |
| Long-term debt | 414 | 1 318 | 827 | 1 404 | 1 055 | 960 | 913 | 866 | 818 | 771 |
| Short-term debt | 1 705 | 277 | 629 | 426 | 886 | 1 532 | 1 421 | 1 432 | 1 505 | 1 342 |
| Total debt | 2 119 | 1 595 | 1 456 | 1 830 | 1 941 | 2 492 | 2 334 | 2 298 | 2 323 | 2 113 |
EBITDA margin
10.1%
This company
15.8%
Market median
-36% vs market
20152024
Equity ratio
61.7%
This company
38.2%
Market median
+62% vs market
20152024
Return on equity
15.5%
This company
18.4%
Market median
+16% vs market
20152024
Net profit margin
5.7%
This company
8.1%
Market median
-30% vs market
20152024
Asset turnover
1.67×
This company
1.12×
Market median
+49% vs market
20152024
Debt / equity
0.62×
This company
0.62×
Market median
+0% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CT Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 | — | — |
PA Audit | Audit | 2022 | — | — |
GS Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KLARDENT AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carla Tashji Karbosh | Deputy Chief Executive Officer | 0 companies |
| Philip Altinisik | Audit | 0 companies |
| George Shahan | Chief Executive Officer | 0 companies |